The Compound Libraries from TargetMol

TargetMol, one of our brands, offers Compound Libraries with over 8000 small molecule compounds of different types, structures, and scales, aimed at enhancing performance in new drug discovery. These libraries are widely used by research institutions and pharmaceutical companies in complementary screening strategies.

What are Compound Libraries?

A compound library or chemical library is a collection of stored chemical products, generally used in high-throughput screening (HTS) or industrial manufacturing.

Most compounds are approved for marketing by the Food and Drug Administration (FDA), the European Medicines Agency (EMA), or the National Medical Products Administration (NMPA).

Depending on their target and design, our Compound Libraries are classified into several categories:

• Focused Bioactive Libraries
  • Approved/Repurposing: Drug Repurposing Compound Library: All the drugs approved and included in this library are listed in the United States Pharmacopeia (USP), British Pharmacopeia (BP), European Pharmacopeia (EP), Japanese Pharmacopeia (JP), or the Chinese Pharmacopeia (CP).
  • Feature Bioactive Libraries: PPI Inhibitor Library
  • Disease-Focused Libraries: Anti-Metabolism Disease Compound Library
  • General Bioactive Libraries: Bioactive Compound Library
  • Target/Pathway-Focused Libraries: DNA Damage & Repair Compound Library
• Natural Product Libraries
  • Natural Product Library for HTS: Natural Product Library for HTS
  • Feature Natural Product Library: RO5 Drug-like Natural Product Library
  • Natural Product Derivatives Libraries: Natural Product Derivatives Library for CADD
  • TCM (Traditional Chinese medicine) Natural Product Library: Traditional Chinese Medicine Monomer Library
  • Structure-Classified Natural Product Library: Terpene Natural Product Library
  • Activity-Classified Natural Product Library: Anti-infective Natural Product Library
• Fragment Libraries
  • Feature Fragment Libraries: Drug-Fragment Library
  • General Fragment Libraries: High Solubility Fragment Library 
• Drug-like Compound Libraries
  • HTS/HCS Compounds (High-throughput screening and high-content screening): Golden Scaffold Library
• Research Field
  • Anti-infectives: Antibiotics Library
  • Cardiovascular Diseases: Anti-Cardiovascular Disease Compound Library
  • Development and Reproduction: Cell Cycle Compound Library
  • Digestive Disorders: Drug-induced Liver Injury (DILI) Compound Library
  • Inflammation and Immunity: Immunology/Inflammation Compound Library
  • Metabolic Diseases: Anti-Metabolism Disease Compound Library
  • Neurological Disorders: Anti-Nervous System Disease Library
  • Tumour/Cancer: Anti-Cancer Compound Library

All these libraries and their screening approaches have particular advantages and disadvantages, but together they provide a powerful tool for identifying promising compounds in new drug discovery.

For more information, visit our website: TargetMol Compound Libraries. Feel free to contact our sales team if you need personalised assistance or have any questions.